Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05007288 · ClinicalTrials.gov registry record · NA

Restorative Eye Treatment and INhance in Upper Eyelid Blepharoplasty Surgery

A NA study, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT05007288 is a NA study that has completed, run by University of Miami. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05007288, a NA study, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

The purpose of this research is to determine if restorative eye treatment (RET) and Inhance with trihex technology used before and after blepharoplasty can lead to better skin quality before undergoing blepharoplasty, and if these products will lead to less visible scarring and faster healing after blepharoplasty.

Interventions

  • OTHER Restorative Eye Treatment (RET) cream
  • OTHER INhance with Trihex Technology

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2020-05-01
Est. Completion 2022-07-30
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT05007288

The ClinicalTrials.gov registry entry for NCT05007288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Restorative Eye Treatment (RET) cream is the first listed.

NCT05007288 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05007288 about?

NCT05007288 is a clinical study titled "Restorative Eye Treatment and INhance in Upper Eyelid Blepharoplasty Surgery". The purpose of this research is to determine if restorative eye treatment (RET) and Inhance with trihex technology used before and after blepharoplasty can lead to better skin quality before undergoing blepharoplasty, and if these products will lead to less visible scarring and faster healing after ...

What is the current status of trial NCT05007288?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2020-05-01. Estimated completion is 2022-07-30.

What interventions are being tested in trial NCT05007288?

The interventions under investigation include: Restorative Eye Treatment (RET) cream (OTHER), INhance with Trihex Technology (OTHER).

Who is sponsoring clinical trial NCT05007288?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.